share_log

丽珠医药拟注销628.375万份股票期权

Livzon Pharmaceuticals plans to cancel 6283.75 million stock options

新浪港股 ·  May 13 20:16

Lizhu Pharmaceuticals (01513) announced that since the company's 2022 stock option incentive plan granted the second stock option exercise period for the first time (total of 5283,500 options) and the reservation to grant the first exercise period (total of 1.0 million options) did not meet company-level performance standards, current options cannot be exercised. The board of directors of the company agreed to cancel a total of 6.28375 million of the above stock options.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment